P. Ballesteros

Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme

C. Schulte, Danny Wende, D. Hertle, 2021, The European Journal of Health Economics.

Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany

L. Wieler, C. Scheidt-Nave, C. König, 2022, PLoS medicine.

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

M. Ramos, S. Morales, A. Oltra, 2007, Cancer Chemotherapy and Pharmacology.

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

M. Ramos, S. Morales, A. Oltra, 2003, Cancer Chemotherapy and Pharmacology.

Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer

R. López, R. Pérez-Carrión, J. Dorta, 2003, Medical oncology.

Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19

L. Wieler, C. Scheidt-Nave, D. Hertle, 2021, medRxiv.

Incident autoimmune diseases in association with a SARS-CoV-2 infection: A matched cohort study

C. Scheidt-Nave, T. Buschmann, L. Reitzle, 2023, medRxiv.

Development of a risk score to identify patients at high risk for a severe course of COVID-19

C. König, J. Walker, A. Schramm, 2023, Zeitschrift fur Gesundheitswissenschaften = Journal of public health.

Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs.

E. Alba, J. J. Bretón, L. Alonso, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

6P Clinical and molecular characteristics in non-small cell lung cancer patients with alteration in PIK3 pathway

J. Castillo, P. López, A. Santón, 2021 .